Home
LENZ
LENZ News

Latest LENZ Therapeutics Inc. Common Stock (LENZ) News on November 22, 2024

LENZ Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

10 days ago

LENZ Therapeutics to Participate in Upcoming Investor Conferences

LENZ Therapeutics Reports Third Quarter 2024 Financial Results

GlobeNewswire

16 days ago

LENZ Therapeutics Reports Third Quarter 2024 Financial Results

LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024

GlobeNewswire

23 days ago

LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024

CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100

GlobeNewswire

25 days ago

CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100

Lenz Therapeutics announces FDA acceptance of NDA for LNZ100

TipRanks

a month ago

Lenz Therapeutics announces FDA acceptance of NDA for LNZ100

GlobeNewswire

a month ago

LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia

GlobeNewswire

2 months ago

LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences

LENZ Therapeutics Insiders Up US$178k On US$551.1k Investment

Simply Wall St.

2 months ago

LENZ Therapeutics Insiders Up US$178k On US$551.1k Investment

GlobeNewswire

3 months ago

LENZ Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

3 months ago

LENZ Therapeutics Reports Second Quarter 2024 Financial Results

GlobeNewswire

3 months ago

LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia

GlobeNewswire

3 months ago

LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

GlobeNewswire

4 months ago

LENZ Therapeutics Announces $30 Million Investment from Ridgeback Capital

We Think LENZ Therapeutics (NASDAQ:LENZ) Can Afford To Drive Business Growth

Simply Wall St.

5 months ago

We Think LENZ Therapeutics (NASDAQ:LENZ) Can Afford To Drive Business Growth

GlobeNewswire

5 months ago

LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024

GlobeNewswire

6 months ago

LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

6 months ago

LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire

7 months ago

LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

Business Wire

8 months ago

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials

Business Wire

8 months ago

LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials

Share on Social Networks: